Skip to main content

MW 553.7 Da, Purity >98%. Widely used as a cell-permeable, reversible, competitive protein kinase C inhibitor. Also potently inhibits wide range of kinases inlcuding RSK1, RSK2, PRK2, PKCα, PKD1, MSK1, GSK3β, CDK2-cyclin A and PIM3, as well as PKCα.

Also available in simple stock solutions (ab146723) - add 1 ml of water to get an exact, ready-to-use concentration.

Be the first to review this product! Submit a review

Images

Chemical Structure - Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor (AB120374), expandable thumbnail
  • Functional Studies - Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor (AB120374), expandable thumbnail

Publications

Key facts

CAS number
138489-18-6
Purity
> 98%
Molecular weight
553.7 Da
Molecular formula
C26H27N5O5S2
PubChem identifier
11628205
Nature
Synthetic

Alternative names

Recommended products

MW 553.7 Da, Purity >98%. Widely used as a cell-permeable, reversible, competitive protein kinase C inhibitor. Also potently inhibits wide range of kinases inlcuding RSK1, RSK2, PRK2, PKCα, PKD1, MSK1, GSK3β, CDK2-cyclin A and PIM3, as well as PKCα.

Also available in simple stock solutions (ab146723) - add 1 ml of water to get an exact, ready-to-use concentration.

Key facts

Purity
> 98%
PubChem identifier
11628205
Solubility

Soluble in DMSO and organic solvents. Solubility in these solvents is approximately 20 mg/mL.

Biochemical name
Bisindolylmaleimide IX mesylate
Biological description

Widely used as a cell-permeable, reversible, competitive protein kinase C inhibitor. Also potently inhibits wide range of kinases inlcuding RSK1, RSK2, PRK2, PKCα, PKD1, MSK1, GSK3β, CDK2-cyclin A and PIM3, as well as PKCα.

Also available in simple stock solutions (ab146723) - add 1 ml of water to get an exact, ready-to-use concentration.

Canonical SMILES
CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N.CS(=O)(=O)O
InChI
InChI=1S/C25H23N5O2S.CH4O3S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20;1-5(2,3)4/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32);1H3,(H,2,3,4)
InChIKey
SAWVGDJBSPLRRB-UHFFFAOYSA-N
IUPAC name
methanesulfonic acid;3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl carbamimidothioate

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions, The product can be stored for up to 12 months

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

ERK2 also known as extracellular signal-regulated kinase 2 is a protein that plays a role in the MAP kinase signaling pathway which is important for various cellular processes. It has a mass of approximately 42 kDa. ERK2 expression occurs across many tissues with high levels in the brain heart and skeletal muscle. SIRT2 or sirtuin 2 is an NAD+-dependent deacetylase involved in metabolic regulation and has a mass of about 43 kDa. It is found in the cytoplasm and nuclear compartments in several cell types. HIPK1 or homeodomain-interacting protein kinase 1 functions as a serine/threonine kinase and its mass is about 133 kDa. It is expressed in the nucleus in tissues including the brain and kidney.

Biological function summary

ERK2 SIRT2 and HIPK1 participate in significant cellular regulation. ERK2 acts in signal transduction to regulate cell division and differentiation. SIRT2 deacetylates proteins contributing to the regulation of glucose homeostasis and stress responses. HIPK1 interacts with transcription factors modulating gene expression in response to cellular stress. These proteins might participate in larger complexes that influence cellular responses tissues development and homeostasis.

Pathways

ERK2 is an important component of the MAPK/ERK pathway involved in transmitting signals from the cell surface to the DNA influencing growth and survival. SIRT2 participates in the regulation of the insulin signaling pathway affecting metabolic processes. Both proteins intersect through their modulation of cell cycle progression and apoptotic pathways. HIPK1 plays roles in the Wnt signaling pathway linking to transcriptional regulation and cell fate determination and it also interacts with proteins in these pathways to influence cell survival and differentiation.

Associated diseases and disorders

ERK2 SIRT2 and HIPK1 serve as contributors to different pathological conditions. Hyperactivity of ERK2 correlates with cancer progression due to its impact on cell proliferation. SIRT2 involvement connects to neurodegenerative diseases like Parkinson’s through its regulation of cellular stress responses. HIPK1's dysregulation may link to cancer development as well. These proteins often engage with others like protein kinase A (PKA) in cancer or alpha-synuclein in neurodegenerative disorders influencing disease outcomes and progression.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Chemical Structure - Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor (ab120374), expandable thumbnail

    Chemical Structure - Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor (ab120374)

    2D chemical structure image of ab120374, Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor

  • Functional Studies - Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor (ab120374), expandable thumbnail

    Functional Studies - Ro 31-8220 mesylate (Bisindolylmaleimide IX), Protein kinase inhibitor (ab120374)

    1.5 x 10e7 THP-1 cells were incubated with 100 nM GF 109203X (GF 109203X (Bisindolylmaleimide i), PKC inhibitor ab144264) or Ro 31-8220 mesylate (ab120374) for 30 minutes prior to activation with 10 μg x mL-1 PMA (Sigma) for 4 hours. Control cells were left without inhibitors or PMA. Cells were lysed in 1 mL of lysis buffer, and 30 μL were tested for PKC activity (duplicates; +/- SD).

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com